Arcutis Biotherapeutics, Inc. has grown revenue 367% a year over three years. Revenue growth, 3-year annual rate: +367% (Biotechnology median +21%). Years of annual history on file: 8, FY2018 to FY2025, as filed.

ARQTArcutis Biotherapeutics, Inc.

HealthcareUSD

$25.16

$14.1952 weeks$31.20

Is it growing?

Is ARQT growing?

Arcutis Biotherapeutics, Inc. has grown revenue 367% a year over three years.

+367%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from fiscal-year columns as filed

Years of annual history on file: 8
Years of annual history on file · FY2018 to FY2025, as filed

Details›

Revenue FY2021: $0
Revenue FY2022: $3.7M
Revenue FY2023: $60M
Revenue FY2024: $197M
Revenue FY2025: $376M

Annual income statements as filed with the SEC.

Biotechnology

Ranks #14 of 145 by Smart Score

Dyne Therapeutics, Inc.

GPCR+0.19%

Structure Therapeutics Inc.

PBLS-3.5%

Parabilis Medicines, Inc.

BEAM+0.09%

Beam Therapeutics Inc.

ALMS+0.72%

Alumis Inc.